Variability or conservation of hepatitis C virus hypervariable region 1? Implications for immune responses

Mario U. Mondelli, Antonella Cerino, Annalisa Meola, Alfredo Nicosia

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The hypervariable region 1 (HVR1) of the E2 protein of hepatitis C virus (HCV) is highly heterogeneous in its primary sequence and is responsible for significant inter- and intra-individual variation of the infecting virus, which may represent an important pathogenetic mechanism leading to immune escape and persistent infection. A binding site for neutralizing antibodies (Ab) has also been allegedly identified in this region. Prospective studies of serological responses to synthetic oligopeptides derived from naturally-occurring HVR1 sequences showed promiscuous recognition of HVR1 variants in most patients via binding to C-terminal amino acid residues with conserved physicochemical properties. Monoclonal antibodies generated by immunization of mice with peptides derived from natural HVR1 sequences were shown to recognize several HVR1 variants in line with evidence gathered from studies using human sera. In addition, selected mAbs were able to bind HVR1 in the context of a complete soluble form of the E2 glycoprotein, indicating recognition of correctly folded sequences, and were shown to specifically capture circulating and recombinant HCV particles, suggesting that HVR1 is expressed on intact virus particles and therefore potentially able to interact with cellular receptor(s). These findings suggest that it is possible to induce a broadly reactive clonal immune response to multiple HCV variants and that this mechanism could be used in principle to induce protective immunity for a large repertoire of HCV variants.

Original languageEnglish
Pages (from-to)305-310
Number of pages6
JournalJournal of Biosciences
Volume28
Issue number3
Publication statusPublished - Apr 2003

Fingerprint

Hepatitis C virus
Viruses
Hepacivirus
Conservation
immune response
Virion
virion
Oligopeptides
Neutralizing Antibodies
oligopeptides
Immunity
Immunization
Glycoproteins
prospective studies
Binding Sites
neutralizing antibodies
Monoclonal Antibodies
Prospective Studies
Amino Acids
glycoproteins

Keywords

  • Hepatitis C virus
  • Hypervariable region 1
  • Immune response
  • Monoclonal antibodies

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)

Cite this

Variability or conservation of hepatitis C virus hypervariable region 1? Implications for immune responses. / Mondelli, Mario U.; Cerino, Antonella; Meola, Annalisa; Nicosia, Alfredo.

In: Journal of Biosciences, Vol. 28, No. 3, 04.2003, p. 305-310.

Research output: Contribution to journalArticle

@article{3b0a928a008545858b63a1b5ea4d9dba,
title = "Variability or conservation of hepatitis C virus hypervariable region 1? Implications for immune responses",
abstract = "The hypervariable region 1 (HVR1) of the E2 protein of hepatitis C virus (HCV) is highly heterogeneous in its primary sequence and is responsible for significant inter- and intra-individual variation of the infecting virus, which may represent an important pathogenetic mechanism leading to immune escape and persistent infection. A binding site for neutralizing antibodies (Ab) has also been allegedly identified in this region. Prospective studies of serological responses to synthetic oligopeptides derived from naturally-occurring HVR1 sequences showed promiscuous recognition of HVR1 variants in most patients via binding to C-terminal amino acid residues with conserved physicochemical properties. Monoclonal antibodies generated by immunization of mice with peptides derived from natural HVR1 sequences were shown to recognize several HVR1 variants in line with evidence gathered from studies using human sera. In addition, selected mAbs were able to bind HVR1 in the context of a complete soluble form of the E2 glycoprotein, indicating recognition of correctly folded sequences, and were shown to specifically capture circulating and recombinant HCV particles, suggesting that HVR1 is expressed on intact virus particles and therefore potentially able to interact with cellular receptor(s). These findings suggest that it is possible to induce a broadly reactive clonal immune response to multiple HCV variants and that this mechanism could be used in principle to induce protective immunity for a large repertoire of HCV variants.",
keywords = "Hepatitis C virus, Hypervariable region 1, Immune response, Monoclonal antibodies",
author = "Mondelli, {Mario U.} and Antonella Cerino and Annalisa Meola and Alfredo Nicosia",
year = "2003",
month = "4",
language = "English",
volume = "28",
pages = "305--310",
journal = "Journal of Biosciences",
issn = "0250-5991",
publisher = "Springer India",
number = "3",

}

TY - JOUR

T1 - Variability or conservation of hepatitis C virus hypervariable region 1? Implications for immune responses

AU - Mondelli, Mario U.

AU - Cerino, Antonella

AU - Meola, Annalisa

AU - Nicosia, Alfredo

PY - 2003/4

Y1 - 2003/4

N2 - The hypervariable region 1 (HVR1) of the E2 protein of hepatitis C virus (HCV) is highly heterogeneous in its primary sequence and is responsible for significant inter- and intra-individual variation of the infecting virus, which may represent an important pathogenetic mechanism leading to immune escape and persistent infection. A binding site for neutralizing antibodies (Ab) has also been allegedly identified in this region. Prospective studies of serological responses to synthetic oligopeptides derived from naturally-occurring HVR1 sequences showed promiscuous recognition of HVR1 variants in most patients via binding to C-terminal amino acid residues with conserved physicochemical properties. Monoclonal antibodies generated by immunization of mice with peptides derived from natural HVR1 sequences were shown to recognize several HVR1 variants in line with evidence gathered from studies using human sera. In addition, selected mAbs were able to bind HVR1 in the context of a complete soluble form of the E2 glycoprotein, indicating recognition of correctly folded sequences, and were shown to specifically capture circulating and recombinant HCV particles, suggesting that HVR1 is expressed on intact virus particles and therefore potentially able to interact with cellular receptor(s). These findings suggest that it is possible to induce a broadly reactive clonal immune response to multiple HCV variants and that this mechanism could be used in principle to induce protective immunity for a large repertoire of HCV variants.

AB - The hypervariable region 1 (HVR1) of the E2 protein of hepatitis C virus (HCV) is highly heterogeneous in its primary sequence and is responsible for significant inter- and intra-individual variation of the infecting virus, which may represent an important pathogenetic mechanism leading to immune escape and persistent infection. A binding site for neutralizing antibodies (Ab) has also been allegedly identified in this region. Prospective studies of serological responses to synthetic oligopeptides derived from naturally-occurring HVR1 sequences showed promiscuous recognition of HVR1 variants in most patients via binding to C-terminal amino acid residues with conserved physicochemical properties. Monoclonal antibodies generated by immunization of mice with peptides derived from natural HVR1 sequences were shown to recognize several HVR1 variants in line with evidence gathered from studies using human sera. In addition, selected mAbs were able to bind HVR1 in the context of a complete soluble form of the E2 glycoprotein, indicating recognition of correctly folded sequences, and were shown to specifically capture circulating and recombinant HCV particles, suggesting that HVR1 is expressed on intact virus particles and therefore potentially able to interact with cellular receptor(s). These findings suggest that it is possible to induce a broadly reactive clonal immune response to multiple HCV variants and that this mechanism could be used in principle to induce protective immunity for a large repertoire of HCV variants.

KW - Hepatitis C virus

KW - Hypervariable region 1

KW - Immune response

KW - Monoclonal antibodies

UR - http://www.scopus.com/inward/record.url?scp=0242585419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242585419&partnerID=8YFLogxK

M3 - Article

C2 - 12734408

AN - SCOPUS:0242585419

VL - 28

SP - 305

EP - 310

JO - Journal of Biosciences

JF - Journal of Biosciences

SN - 0250-5991

IS - 3

ER -